IntrinsicIntrinsic
← Scroll for more →

Zoetis Inc. (ZTS)

Pharmaceutical Preparations

Latest Price
$79.72
TTM P/E
13.13
Normalized P/E
15.15
TTM Div Yield
1.33%
Fwd Div Yield
2.66%
Book Value
7.51
P/B Ratio
10.62

Valuation metrics

adjust assumptions →
EPS: $6.02
Book value / share: $7.84
Formula: √(22.5 × EPS × BVPS)
Graham Number
$32.59
58% downside
Norm. op. income: $2.9B (median of 7yr)
Tax rate: 20%
Discount rate: 10%
Growth assumption: zero (EPV is a no-growth value)
Earnings Power Value
$38.12
51% downside
Base FCF: $1.7B (median of recent 5yr)
Growth: 13%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$110.41
+42% upside
EPS: $6.02
Target P/E: 15×
Formula: EPS × P/E
P/E Fair Value
$90.30
+16% upside

Institutional Ownership

94.8% held by institutions
InstitutionSharesValueOwnership %ChangeFiling Date
BlackRock, Inc.39.43M$2.83B9.52%+3.85M2026-06-30
Vanguard Capital Management LLC26.03M$1.87B6.28%-44.9K2026-06-30
Vanguard Portfolio Management LLC23.86M$1.71B5.76%-107.0K2026-06-30
State Street Corp19.67M$1.41B4.75%+343.3K2026-06-30
State Farm Mutual Automobile Insurance Co15.89M$1.14B3.84%--2026-06-30
Geode Capital Management, LLC13.29M$951.0M3.21%+1.94M2026-06-30
Wellington Management Group LLP9.42M$677.0M2.28%-726.2K2026-06-30
Morgan Stanley8.88M$638.0M2.14%-5.27M2026-06-30
Nordea Investment Management AB6.59M$471.0M1.59%+727.5K2026-06-30
Deutsche Bank AG\5.85M$420.0M1.41%+319.7K2026-06-30
View all institutional holders →